Stocks · Korea 001630 KOSPI

Chongkundang Holdings

37,550원 +0.54% Market cap 1,881억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER4.42x
PBR0.28x
EPS8,493 KRW
BPS133,813 KRW
ROE6.97%
DPS1,400 KRW

Returns and 52-week range

1W+0.94%
1M-3.47%
3M-6.59%
6M-21.36%
1Y-23.99%
YTD-17.20%
52W high55,600원
52W low35,300원
From 52W high-32.46%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20229,090억-329억-227억-3.6%
20238,798억170억406억1.9%
20249,578억355억403억3.7%
20259,590억583억543억6.1%
Quarterly
2024 4Q2,271억69억68억3.0%
2025 1Q2,466억119억78억4.8%
2025 2Q2,422억165억114억6.8%
2025 3Q2,342억181억200억7.7%
2025 4Q2,360억118억151억5.0%
2026 1Q2,403억193억179억8.0%

Company

CEO최희남
Founded1956-01-10
Fiscal year end12
Address: 서울특별시 서대문구 충정로 8 종근당빌딩

Peers in the same sector

CompanyMarket capP/EP/B1M
환인제약1,893억11.880.45-2.02%
삼일제약1,850억—1.36+40.30%
이연제약1,903억—0.85+3.33%
대원제약1,850억—0.66+3.25%
한국유니온제약1,924억——+0.00%
셀비온1,827억—7.97+17.90%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.